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EMERGING AND TRANSITIONING COUNTRIES’  
ROLE IN GLOBAL HEALTH 
JENNIFER PRAH RUGER, Ph.D.* AND NORA Y. NG, Ph.D.** 
I.  INTRODUCTION 
Global health scholarship has failed to adequately consider the “BRIC” 
cluster of nations—Brazil, Russia, India and China—particularly in the 
aggregate.  An article search with the keywords “BRIC” and “public health” 
yields just one publication.  But these countries have a unique role to play in 
the global health enterprise by addressing global health problems as they 
build their own health systems and help developing countries improve their 
populations’ health.  Moreover, the BRIC nations are becoming increasingly 
important components of the global health architecture, individually as 
nations and collectively as a nexus of influence.  In June 2009, the countries 
held the first-ever BRIC summit in Yekaterinburg, Russia, debuting as a 
policy consultation and coordination group.1 
What these countries collectively have to offer in the quest to improve 
global health merits attention.  This article focuses on the role of emerging 
and transitioning countries as actors in (1) providing financial assistance to 
lower-income countries; (2) supplying medical goods and services to the 
developing world; (3) giving technical assistance; (4) improving access to 
medicines and intellectual property; (5) modeling effective health-sector 
framework-building to less developed countries; (6) delivering object lessons 
learned from the health and development process; (7) helping lower-income 
countries grow their economies and reduce poverty; (8) taking a significant 
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 1. Tony Halpin, Brazil, Russia, India and China Form Bloc to Challenge U.S. Global 
Dominance, TIMES, June 17, 2009, at 33. 
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role in global health governance; and (9) bolstering the link between health 
and foreign policy.  For all their growing power and potential, however, they 
are still emerging and transforming countries with their own daunting and 
persisting health challenges that require continuing assistance from the 
global health community. 
II.  POTENTIAL BRIC CONTRIBUTIONS TO THE GLOBAL HEALTH ENTERPRISE 
A. Providing Financial Assistance 
Given their growing financial resources,2 emerging countries have a 
rightful role in providing financial assistance to developing countries.  
Emerging countries invest in health care, public health, and disease-specific 
programs in developing countries.3  India, for example, has financed 
Human Immunodeficiency Virus (“HIV”) and Acquired Immune Deficiency 
Syndrome (“AIDS”) programs in several African countries.4  Indian 
pharmaceutical companies have built production facilities in Africa and Latin 
America, playing a “pivotal” role in lowering the prices of antiretroviral 
drugs to affordable levels in developing countries,5 while also expanding 
jobs and economic development. 
The existing international development architecture leaves gaps in health 
system development.  Emerging countries, in conjunction with international 
organizations, can help fill the gaps by raising awareness and advocating 
for financial assistance.  In 2004, for instance, the president of Brazil, Lula 
da Silva, along with Chile, France, and then-UN Director-General Kofi 
Annan, called for a “global political alliance” to support a global fund for 
hunger and poverty.6  At their 2009 summit, BRIC issued a statement on 
global food security calling for financial and technical support in food 
production, the sustainability of biofuels use and production, and the 
reduction of agricultural subsidies.7  In May 2010, BRIC agricultural 
ministers signed a global food security declaration, with the aims of 
 
 2. Id. (stating that the BRIC nations represent forty percent of the world’s population and 
fifteen percent of the world’s gross domestic product). 
 3. See infra notes 4-5, 15-16, 20-21, 23 and accompanying text (illustrating examples 
of emerging countries investing in developing countries). 
 4. J. STEPHEN MORRISON & JENNIFER KATES, CTR. FOR STRATEGIC & INT’L STUDIES (CSIS) & 
KAISER FAMILY FOUND., THE G-8, RUSSIA’S PRESIDENCY, AND HIV/AIDS IN EURASIA: A REPORT TO 
THE CSIS TASK FORCE ON HIV/AIDS IN COLLABORATION WITH THE KAISER FAMILY FOUNDATION 4 
(2006), available at http://csis.org/files/media/csis/pubs/060614_g8aids.pdf, at 4. 
 5. Id. 
 6. John Zarocostas, Brazil Drives Efforts to Fight Hunger and Poverty, 363 LANCET 462, 
462 (2004). 
 7. President of Russia Official Web Portal, BRIC’s Joint Statement on Global Food 
Security (June 16, 2009), http://archive.kremlin.ru/eng/text/docs/2009/06/217964.shtml. 
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developing a strategy to ensure food access for vulnerable populations, 
creating an agriculture information system, adapting to climate change, and 
improving agricultural technological innovation and cooperation.8 
BRIC nations are prosperous enough to have transitioned to “donor” 
status in international development assistance.  All four BRIC countries are 
donors to The Global Fund.9  India became the fifteenth largest donor to 
the World Food Program in 2005, and in 2004 lent more than $400 
million in hard currency to Brazil, Burundi, and Indonesia, under the 
Financial Transactions Plan of the IMF.10  Russia has also provided bilateral 
foreign assistance to a number of countries, including Cuba, Iran, 
Chechnya, Kyrgyzstan, Iraq, China, Lebanon, Palestine, Afghanistan, Serbia, 
and Iceland, though the bulk of this assistance is for economic or 
geopolitical reasons and not for public health.11  China, too, gives aid to 
African countries in the form of debt write-offs, preferential loans, buyer’s 
credit, investment, training, and building of infrastructure, with the declared 
 
 8. Michael Lucivero, BRIC Ministers Sign Global Food Security Pact (Apr. 5, 2010).  
http://foodcrisis.foreignpolicyblogs.com/2010/04/05/bric-countries-sign-food-security-pact/. 
 9. The Global Fund, The Global Fund’s Donor Governments, http://www.theglobal 
fund.org/en/donors/list/ (last visited Sep. 2, 2010).  China, India, and Russia are listed as 
current donors in the Second Replenishment Cycle 2008-2010, and Brazil is listed as having 
contributed previously. 
 10. Dweep Chanana, India as an Emerging Donor, 44 ECON. & POL. WEEKLY 11, 12 
(2009). 
 11. Megan K. Stack, Hillary Clinton, Russians Clash Publicly Over Iran Reactor, L.A. 
TIMES, Mar. 19, 2009, http://articles.latimes.com/2010/mar/19/world/la-fg-clinton-russia19-
2010 mar19 (Russia involved in building Iran’s nuclear power plant); Conor Sweeney & Oleg 
Shchedrov, Russia Offers Allies Aid as U.S. Base Ordered Shut, REUTERS, Feb. 3, 2009, 
http://www.reuters.com/article/idUSTRE51227720090203 (Russia gave aid packages worth 
$150 and $354 million to Kyrgyzstan and Cuba, respectively); Iceland Turns to Russia for 
Bailout, RIA NOVOSTI, Oct. 10, 2008, http://en.rian.ru/analysis/20081010/117659587.html 
(Russia bails out Iceland by granting “huge stabilization loan at an unbelievably low interest 
rate”); Russia’s Aid to Quake-Hit China Totaled $14 Million, RIA NOVOSTI, July 16, 2008, 
http://en.rian.ru/world/20080716/114099714.html; Russia May Continue Giving Aid to 
Palestine—Foreign Ministry, RIA NOVOSTI, May 8, 2006, http://en.rian.ru/russia/20060508/ 
47870322.html (Russia provided $10 million to Palestine for social and humanitarian needs); 
Russia Offers Afghanistan Aid in Establishing Political System, RIA NOVOSTI, June 15, 2009, 
http://en.rian.ru/russia/20090615/155259203.html; Russia Promise on Chechnya Aid, BBC 
NEWS, Jan. 28, 2000, http://news.bbc.co.uk/2/hi/europe/621724.stm; Russia Proposes Aid 
to Lebanon to Rebuild Infrastructure, RIA NOVOSTI, Sep. 7, 2006, http://en.rian.ru/russia/ 
20060907/53602293.html; Russia Sends Humanitarian Aid to Iraq, CHINA VIEW, Dec. 25, 
2004, http://news.xinhuanet.com/english/2004-12/25/content_2380273.htm (Russia sent 
tents, blankets, heating appliances, lighting appliances, medicine, medical equipment, and 
antiseptics to Iraq as humanitarian aid); Third Plane with Russian Humanitarian Aid Lands in 
Serbia, RIA NOVOSTI, Apr. 8, 2008, http://en.rian.ru/russia/20080408/104031974.html. 
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goal of “mutual” economic benefit.12  At the BRIC summit, Chinese 
President Hu Jintao offered ten billion dollars of credit support to the 
countries of Central Asia to help deal with the global economic recession.13  
While observers have noted that “China’s health sector is overwhelmingly 
internally focused,”14 China does undertake some medical financial aid in 
Africa.15  According to a 2006 report by China’s official press agency, the 
Chinese government planned to build thirty hospitals and thirty malaria 
prevention and treatment demonstration centers, and to provide about 
$37.5 million in grants for anti-malarial drugs.16  Although most of Russian 
and Chinese foreign aid does not currently directly target health, it does 
suggest that these emerging countries are in position to provide health-
related financial assistance if health becomes a larger part of their foreign 
policy agenda. 
Indian foreign financial aid is similar to China’s in that it tends to be 
oriented toward the economy and trade.  As a donor, it has been remarked 
that India appears in another country “only when it is also an investor, trade 
partner or political ally, or can become one.”17  India has a long-standing 
practice of economic and military aid in South Asia—it funds almost sixty 
percent of Bhutan’s budget, and gives aid and loans to Afghanistan, Nepal, 
and Myanmar.18  Partly in competition with China, India has branched out 
to Africa.  In 2009, India doubled the amount set aside for loans to Africa 
to $5.2 billion, and Africa is now one of the largest recipients of Indian 
development assistance.19  However, some of India’s financial aid does go 
toward health purposes such as HIV/AIDS.20 
Health plays a more prominent part in Brazilian foreign financial 
assistance.  In 2007, it was estimated that Brazil spent around $120 million 
worldwide on HIV/AIDS relief programs, the rehabilitation of former 
combatants, and other areas such as agricultural development and 
 
 12. Chinese Aid Flows into Africa, VOANEWS.COM, May 8, 2007, http://www1.voanews. 
com/english/news/africa/a-13-Chinese-Aid-Flows-into-Africa.html. 
 13. Guy Faulconbridge, Developing World Leaders Show New Power at Summits, 
REUTERS, June 16, 2009, http://www.reuters.com/article/idUSTRE55F02F20090616?feed 
Type=RSS&feedName=topNews. 
 14. Qide Han et al., China and Global Health, 372 LANCET 1439, 1439 (2008). 
 15. Id. 
 16. China, Africa Vow Closer Cooperation in Fighting HIV/AIDS: Action Plan, PEOPLE’S 
DAILY ONLINE, Nov. 6, 2006, http://english.peopledaily.com.cn/200611/06/eng20061106_ 
318575.html. 
 17. MATTHIAS JOBELIUS,  NEW POWERS FOR GLOBAL CHANGE? CHALLENGES FOR THE 
INTERNATIONAL DEVELOPMENT COOPERATION: THE CASE OF INDIA 2 (FRIEDRICH EBERT STIFTUNG, 
2007), available at http://library.fes.de/pdf-files/iez/global/04718.pdf. 
 18. Chanana, supra note 10, at 11. 
 19. Id. at 12. 
 20. MORRISON & KATES, supra note 4. 
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vocational training.21  Brazil’s largest beneficiaries include Paraguay, East 
Timor, Haiti, Mozambique, Angola, and Guinea-Bissau.22  Financial aid 
also contributes to infrastructure development, such as the building of a 
pharmaceutical laboratory for the production of antiretroviral drugs in 
Mozambique.23 
B. Supplying Medical Goods and Services 
Besides financial aid, emerging countries can supply necessary medical 
goods and services, both by directly exporting to developing countries and 
exemplifying the usefulness of domestic generic drug industries.  For 
example, Brazil has developed a significant generic drug industry that has 
helped the government in its attempt to provide free antiretroviral (“ARV”) 
medications to all individuals who need them.24  Both India and China 
manufacture raw chemicals and ingredients for drug manufacturing, and 
both are major manufacturers of generic drugs, including ARVs, for 
domestic use and international export.25  In fact, Brazil purchases active 
pharmaceutical ingredients from India and China and then domestically 
produces ARVs for its own population.26  India especially is an important 
source of ARVs for countries that cannot produce their own.27  It is also 
branching out to make other complex medications (such as for cancer) and 
undertaking pharmaceutical research and development.28 
Drugs are not the only exported medical supply.  India’s Aravind Eye 
Care System, for instance, produces intraocular lenses used in cataract 
 
 21. CATRINA SCHLÄGER, NEW POWERS FOR GLOBAL CHANGE? CHALLENGES FOR THE 
INTERNATIONAL DEVELOPMENT COOPERATION: THE CASE OF BRASIL 6 (FRIEDRICH EBERT STIFTUNG, 
2007), available at http://www.nuso.org/upload/fes_pub/schlager.pdf. 
 22. José Soares Jr., Brazil as a South-South Cooperation Partner, in IT’S TIME FOR BRAZIL IN 
SINGAPORE 50, 51-52 (Tatiana Rosito ed., 2008), available at http://www.brazil.org.sg/ 
Download/brazil08.pdf. 
 23. Eduardo J. Gómez, Brazil’s Blessing in Disguise, FOREIGN POL., July 22, 2009, 
http://www.foreignpolicy.com/articles/2009/07/22/brazils_blessing_in_disguise (last visited 
Sep. 2, 2010). 
 24. Jon Cohen, Ten Years After, 313 SCIENCE 484, 484 (2006). 
 25. CHERI GRACE, THE EFFECT OF CHANGING INTELLECTUAL PROPERTY ON PHARMACEUTICAL 
INDUSTRY PROSPECTS IN INDIA AND CHINA: CONSIDERATIONS FOR ACCESS TO MEDICINES 14 
(2004), http://www.dfidhealthrc.org/publications/atm/Grace2.pdf. 
 26. Cohen, supra note 24, at 484, 487. 
 27. Grace, supra note 25, at 14-15. 
 28. Heather Timmons, India Expands Role as Drug Producer, N.Y. TIMES, July 6, 2010, 
http://www.nytimes.com/2010/07/07/business/global/07indiadrug.html; Sachin Chaturvedi, 
Emerging Indian Entrepreneurship in Biotechnology and National Innovation System: 
Exploring Linkages and Prospects, 5 INT. J. TECHNOL & GLOBAL. 76 (2010). 
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surgery through its own Aurolab facility.29  Producing its own lenses allowed 
Aravind to cut lens costs from $200 to less than ten dollars, and Aurolab 
lenses are now exported through various NGO partners and distribution 
venues to more than one hundred countries, making up ten percent of the 
global market.30 
Services are exportable too; BRIC’s export is an increasingly important 
short-term remedy to fill gaps in human resources for health and to address 
the brain-drain problem in many countries.  Russia has been active in 
staffing select African HIV programs31 and has sent doctors and supplies to 
disaster areas like Haiti and Chile in the wake of their recent devastating 
earthquakes.32  China, as part of its diplomatic engagement with Africa, 
provides medical supplies free of charge to some African countries, and 
runs training programs for diseases including malaria and HIV/AIDS.33  
Since 1964, China has “cumulatively sent over 15,000 doctors to more 
than 47 African countries and treated approximately 180 million African 
patients[.]”34  The recipient African countries pay the costs of these medical 
teams, but for the poorest recipients China covers the teams’ travel costs 
and the supplies the teams bring along.35 
Even countries without BRIC’s growing economic and financial heft can 
provide important medical services.  Cuba is an exporter of medical aid.36  
Cuban health assistance programs have sent teams of doctors to disaster 
areas such as Haiti after Hurricane Mitch in 1998 and to Pakistan after the 
earthquake in 2005.37  Cuban doctors can be found working in remote and 
underserved areas in countries like Honduras,38 Belize,39 and Equatorial 
 
 29. Aman Bhandari et al., Specialty Care Systems: A Pioneering Vision for Global Health, 
27 HEALTH AFF. 964, 970 (2008). 
 30. Id. 
 31. MORRISON & KATES, supra note 4, at 4. 
 32. Russian Humanitarian Aid Arrives in Quake-Hit Chile, RIA NOVOSTI, Mar. 5, 2010, 
http://en.rian.ru/russia/20100305/158097559.html; Russia to Send Two More Aid Planes to 
Quake-Hit Haiti, RIA NOVOSTI, Jan. 31, 2010, http://en.rian.ru/russia/20100131/15773040 
7.html. 
 33. Drew Thompson, China’s Soft Power in Africa: From the “Beijing Consensus” to 
Health Diplomacy, CHINA BRIEF, Oct. 13, 2005, http://www.jamestown.org/programs/china 
brief/single/?tx_ttnews%5Btt_news%5D=30973&tx_ttnews%5BbackPid%5D=195&no_cache
=1. 
 34. Id. 
 35. Id. 
 36. Hernando Calvo Ospina, Havana’s Medics Work Around the World; Cuba Exports 
Health, LE MONDE DIPLOMATIQUE, Aug. 2006, http://mondediplo.com/2006/08/11cuba. 
 37. Id. 
 38. Id. 
 39. Michael Voss, Cuba Pushes Its ‘Medical Diplomacy’, BBC NEWS, May 20, 2009, 
http://news.bbc.co.uk/go/pr/fr/-/2/hi/americas/8059287.stm. 
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Guinea.40  Patients also go to Cuba from Latin America and the Caribbean 
for free cataract surgery, courtesy of the Cuban government.41  Possibly the 
most acclaimed medical service Cuba provides is through its medical 
schools, especially its Latin American Medical School, which trains students 
from mainly Latin American, Caribbean, and African countries.42  Cuba 
grants these students full scholarships, on condition that they return to their 
home countries to work once they qualify as doctors.43  Supplying medical 
services to other developing countries has been an effective diplomatic 
strategy for Cuba, helping it develop positive ties around the world despite 
political isolation by the United States.44  It is also a part of Cuban trade.  
Venezuela, for example, subsidizes oil to Cuba in return for the 20,000 
Cuban medical professionals working there.45  The Cuban example 
highlights diplomatic and economic rationales for emerging countries to 
expand their provision of medical supplies and services, and may serve as a 
model for that expansion. 
Other emerging countries serve as regional training centers for scientists 
and researchers as well.  Brazilian universities and institutions train scientists 
from other South American countries, while many African scientists receive 
education in Nigeria, Kenya, and Mali.46  Malaysia, Thailand, and the 
Philippines also train Asian and African researchers, with special emphasis 
on epidemiology.47 
C. Providing Technical Assistance 
In addition to medical goods and services, emerging nations can—and 
do—provide technical assistance.  Brazil created a network with seven other 
middle-income countries to share technology and best practices regarding 
the manufacture of pharmaceuticals.48  Brazil has also furnished technical 
assistance to developing countries through the Brazil+7 initiative, an 
alliance between UNICEF, UNAIDS, the Brazilian government, and seven 
 
 40. Marion Lloyd, A Medical School in Cuba Trains Doctors for Poor Countries, CHRON. 
HIGHER EDUC., July 20, 2001, at A35. 
 41. Voss, supra note 39. 
 42. Lloyd, supra note 40. 
 43. Voss, supra note 39. 
 44. Id. 
 45. Id. (“Medical aid has become a ‘service export.’”). 
 46. Thomas C. Nchinda, Research Capacity Strengthening in the South, 54 SOC. SCI. & 
MED. 1699, 1708 (2002). 
 47. Id. 
 48. Susan Okie, Fighting HIV—Lessons from Brazil, 354 NEW ENG. J. MED. 1977, 1981 
(2006) (Brazil, Argentina, China, Cuba, Nigeria, Russia, Ukraine, and Thailand are working 
together to “improve each country’s capacity to manufacture medicines, condoms, and 
laboratory reagents needed to fight AIDS . . . .”). 
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other countries to increase access to antiretroviral medicine, particularly 
those that prevent mother-to-child-transmission, in partner countries.49  
Treatment programs in those countries have expanded as a result of this 
initiative.50 
China and India are also well placed to offer technical assistance.  In 
addition to China’s training sessions on malaria, HIV, and other diseases in 
Africa, China and India may prove to be especially effective partners in 
research and development.  China is “ranked fourth internationally in 2005 
for patents granted and publications in indexed journals,”51 indicative of its 
strength in research.  India’s human resources and advanced medical 
expertise are also widely acknowledged, and it shows “great initiative and 
commitment” in researching and developing HIV vaccines and 
microbicides.52  To further this endeavor, India established the Global 
Political Advocacy Initiative, which seeks to raise awareness and support for 
an accelerated research and development effort for preventive HIV 
vaccines.53 
Technical assistance is not confined to medications.  India’s Pan African 
E-Network project is set up to provide digital information services, with an 
emphasis on tele-education and tele-medicine, and its Africa-India 
Framework for Cooperation aims to build capacity for medical professionals 
to deal with pandemics.54  China has given billions in concessional loans to 
African countries to further trade, but also to assist in areas such as health 
and medical care.55 
Other emerging countries likewise engage in South-South cooperation.  
A health information system developed in South Africa was transferred to the 
neighboring country Mozambique, which shares similarities in health system 
structure.56  The “physical proximity and feeling of shared interest ease[d] 
 
 49. UNICEF, Saving Lives: “Brazil+7 South-South Cooperation”, http://www.unicef.org/ 
brazil/english/newsline2.htm (last visited Sep. 2, 2010) (The other countries are Sao Tome 
and Principe, Bolivia, Paraguay, Cape Verde, Guinea-Bissau, East Timor, and Nicaragua.). 
 50. Id. 
 51. Zhu Chen, Biomedical Science and Technology in China, 372 LANCET 1441, 1442 
(2008). 
 52. MORRISON & KATES, supra note 4, at 20. 
 53. Id. 
 54. Thalif Deen, China, India Lead South-South Cooperation, INTER PRESS SERVICE NEWS 
AGENCY, Nov. 24, 2009, http://ipsnews.net/news.asp?idnews=49398. 
 55. Id. 
 56. Jens Kaasbøll & Jose Leopoldo Nhampossa, Transfer of Public Sector Information 
Systems Between Developing Countries: South-South Cooperation (unpublished manuscript 
presented at the International Federation for Information Processing Working Group 9.4 
Conference on Social Implications of Computers in Developing Countries, May 29-31, 2002, 
Bangalore, India), http://heim.ifi.uio.no/~jensj/TransferSouthSouth.pdf. 
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the cooperation between the original developers and the adapters.”57  Egypt 
has a Fund for Technical Cooperation with Africa (“EFTCA”), which finances 
and organizes projects such as sending engineers to train workers in 
Cameroon in medical equipment maintenance.58  Egypt also operates other 
technical cooperation programs that target Central Asian and Islamic 
countries.59  Bilateral provision of technical assistance is not the only 
approach.  Emerging countries are partnering with each other in “trilateral 
cooperation” to provide technical assistance to developing countries.60  
Egypt and Turkey cooperate to train Africans in fields like health, agriculture, 
and security.61  Argentina works with PAHO/WHO to offer technical 
assistance in endeavors such as polio eradication in the Nigerian child 
population and to strengthen capacity relating to organ transplants in 
Paraguay.62 
D. Improving Access to Medicines and Intellectual Property 
Emerging countries have begun to claim another critical role in 
improving health—acting in blocs to negotiate intellectual property (“IP”) 
regulations and access to medicines.  Their potential for influence is a topic 
of significant discussion and speculation.63  The expectation is that BRIC 
nations—or individual countries anchoring other coalitions—could bargain 
for more favorable application of intellectual property rights within the 
World Trade Organization (“WTO”) and other international trade venues, 
thereby improving access to essential medicines both for their own 
populations and for those in other needy countries.  Such collective 
strategies are already beginning to play out.  In 2005, for example, Brazil 
reached an agreement between eleven Latin American governments and 
 
 57. Id. at 12. 
 58. INSouth.org, Egypt, http://www.insouth.org/index.php?option=com_content&view= 
article&id=67:egypt&catid=31:country-windows&Itemid=86 (last visited Sep. 2, 2010). 
 59. Id. (Egyptian Fund for Technical Cooperation with Commonwealth and Trilateral 
Cooperation on South-South Basis with Islamic Development Bank). 
 60. Id. (Trilateral Cooperation on South-South Basis with Islamic Development Bank and 
Trilateral Cooperation on South-South Basis with Turkey). 
 61. Id. 
 62. PAN-AMERICAN HEALTH ORGANIZATION, SOUTH-SOUTH COOPERATION: TRIANGULAR 
COOPERATION EXPERIENCE BETWEEN THE GOVERNMENT OF THE ARGENTINE REPUBLIC AND THE PAN-
AMERICAN HEALTH ORGANIZATION/WORLD HEALTH ORGANIZATION 14-16 (2009), http://new. 
paho.org/arg/images/coopSURSUR/css_ing.pdf. 
 63. See, e.g., Peter K. Yu, Access to Medicines, BRICS Alliances, and Collective Action, 
34 AM. J.L. & MED. 345, 355, 358 (2008) (speculating that BRIC countries are “likely to play 
an important role in the development of the international intellectual property regime” and 
“there is no doubt that BRIC[] countries will be economically powerful in the future”). 
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twenty-six drug companies to lower the prices of HIV/AIDS drugs in the 
region.64 
Even without traditional political alliances, the actions and successes of 
BRIC countries in expanding drug access and IP rights can change norms 
and expectations for global actors.  In 2001, at the behest of several 
pharmaceutical firms, the United States planned to bring WTO action 
against Brazil and its drug patent laws.65  Brazil was able to mount effective 
diplomatic and public relations campaigns to lobby the Bush administration 
and to bring international attention to its “fight for life.”66  Washington 
relented in the face of international pressure and a “potential public 
relations disaster.”67  In another instance, thirty-nine pharmaceutical 
companies sued the South African government to block the country from 
importing generic anti-retroviral drugs,68 but they dropped the suit in 2001 
due to negative international opinion.69  BRIC countries have sufficient 
resources to respond actively to threats of IP-related trade sanctions and 
lawsuits—China in particular has the economic clout to play hardball and 
threaten countersanctions in trade negotiations, especially vis a vis the 
United States.70  These actions also have some beneficial repercussions for 
other developing countries.  The Brazilian and South African episodes 
helped raise international awareness and revealed widespread normative 
expectations about essential drug access for the developing world.  The 
potential for hugely negative public relations from IP actions became 
abundantly clear to pharmaceutical companies.  At the very least, these 
lessons make them unlikely to take another developing country to court.71  
Drug companies may also try to garner positive publicity by donating or 
discounting drugs to poor nations, thus more directly increasing access.72 
Some emerging countries are taking more active and assertive measures 
to increase drug access.  Trade-related aspects of intellectual property rights 
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(“TRIPS”), a WTO agreement on intellectual property rights, permits 
governments to allow would-be infringers to produce a patented product 
through compulsory licenses if “reasonable commercial terms” cannot be 
obtained from the right holder, or in case of “national emergency.”73  
Countries have used compulsory licensing mainly as a negotiation tool—
threatening its use to get deeper drug discounts from pharmaceutical 
firms.74  Brazil, which places great importance on the availability of 
inexpensive ARV drugs, has made multiple threats to do so, but only actually 
issued its first compulsory license in 2007, for Merck’s efavirenz.75  Thailand 
is more aggressive.  Thailand has issued compulsory licenses for two 
antiretroviral drugs, efavirenz and lopinavir+ritonavir, which it has 
repeatedly renewed.76  Thailand has acted partly to forestall an upsurge of 
costs in its HIV/AIDS program from the impending failure of generic first-line 
drugs—as the virus develops resistance, expensive patented second-line 
drugs must be introduced.77  Some observers also think that Thai patent 
seizures are a bid by Thailand to develop its generic drug industry into a 
regional hub.78  Whatever Thailand’s reasons may be, countries like Bolivia 
and Brazil have expressed support, and others, like the Philippines, 
considered legislation to follow the Thai example.79  The move by middle-
income countries to seize patents has been described as “a massive political 
movement against intellectual property” that “seeks to make medicine into 
public, not private, goods.”80 
E. Modeling Institutional Frameworks for Health 
Institutional frameworks for health care and public health sectors 
address the regulation of medical equipment, medicines, facilities, and 
worksites; oversight of personnel training, licensing, and accreditation; 
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provision of hospitals, clinics, and health-related facilities; generation and 
dissemination of health-related knowledge and information; and the 
establishment of sustainable, equitable, and affordable health insurance 
systems.  The BRIC countries clearly have room for improvement in these 
areas—they each lack sufficient facilities and supplies, and there have been 
notorious lapses in the regulation of food and drug safety.  China has had 
numerous safety breaches, such as melamine in milk powders and pet food, 
antifreeze chemical in toothpaste, and tainted heparin.81  In India, also, 
investigations have uncovered repeated instances of inaccurate 
dosage/duration in drug prescriptions, and even the lack of such 
information altogether.82  Still, emerging countries offer some encouraging 
examples for other countries to draw upon. 
It would be hard to find a better instance of the development of an 
institutional health care framework than the specialty care model in India.  
India’s Aravind Eye Care System provides a particularly inspiring example of 
the ways in which this specialty approach can build a system from the 
ground up.83  The specialty care or “focused factory” model concentrates on 
a particular medical condition, disease area, medication or procedure and 
relies on standardized methods, management goals, core competencies, 
and an efficient and specialized human capital base.84  The success of this 
model has been attributed to four major features: “(1) implementation of 
management systems that emphasize standardization and continuous 
improvement; (2) the ability to attract and train specialized workforce; (3) 
access to low-cost technology; and (4) generation of patient volume.”85 
As of 2008, the Aravind Eye Care System has five hospitals with 3,950 
beds and examines over two million patients annually.86  The attention to 
standardized methods and specialized human resources with core 
competencies is reflected in Aravind’s “serial production” approach.87  
While an Aravind surgeon operates on one patient, the next patient is 
prepared on the adjacent table.  The surgeon simply swings his or her 
surgical microscope over to the next table to begin the next procedure when 
the surgeon is finished with the last one.  Paramedical staff does simpler 
tasks such as preparing patients and instruments, thus freeing the surgeon to 
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concentrate on surgery alone.88  Standardized procedures and specialized 
staff help maintain quality of care and enable high-volume patient 
treatment.  Aravind surgeons average around 2,000 cataract surgeries per 
year, compared to the Indian national average of 250.89 
The financing system set up by Aravind is progressive, with paying 
patients subsidizing poor patients who receive low-cost or free care.90  As 
mentioned earlier, Aravind’s Aurolab manufactures intraocular lenses 
domestically, allowing huge reductions in costs as well as international 
export.91  Aravind also established its own institute, Lions Aravind Institute of 
Community Ophthalmology (“LAICO”), which pursues system-wide 
improvements in “planning, efficiency, and effectiveness of all eye hospitals 
in India.”92  India’s Cataract Blindness Control Program, a recognized 
international public health success story, used Aurolab lenses and followed 
the Aravind approach.93  Aravind has assisted eye hospitals in other 
countries such as Bangladesh, Tanzania, and China.94  The He Eye Care 
System in China, for instance, has emulated the Aravind model since 
2001.95 
Other examples of specialty care in India include the LifeSpring Hospital 
System (a joint venture between the Acumen Fund and Hindustan Latex to 
provide reproductive and pediatric care to low-income urban mothers and 
their children); the Socjo Foundation (focused on training women in 
communities to identify problems of low vision and sell low-cost eye 
glasses); Jaipur Foot (locally-produced prosthetic limbs adapted for local 
conditions); and the Medicine Shoppe (a leading pharmacy chain that sets 
up healthcare clinics with attached pharmacies in low-income areas to 
provide low-cost care and generic drugs).96  The Aravind and similar 
approaches offer useful models for systems development in other countries, 
although their transplantation should proceed with caution: there might well 
be significant challenges in applying these systems to other contexts and 
more complex areas of health.97 
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Beyond India, China may set an example for infectious disease reporting 
and monitoring in its recently established China Information System for 
Disease Control and Prevention (“CISDCP”).  CISDCP is “the world’s largest 
internet-based disease reporting system,” instituted since the SARS outbreak 
in 2003.98  This system allows hospitals and clinics to report case-based 
information on diseases immediately through the Internet, facilitating the 
identification of outbreak locations and the cluster characteristics of patients 
(e.g., age, sex, occupation) by health officials.99  In 2008, CISDCP 
developed and integrated cellular phone reporting.100  Given the 
increasingly potent threat of communicable diseases in a globalized 
economy, strong nationally-based disease reporting systems are critical, and 
combining what works best at the national level through an integrated 
global system is an essential public health strategy for the twenty-first 
century. 
More active steps are being taken by emerging countries to develop and 
shore up their health sector institutional framework.  An instance of such a 
step was the establishment of a Developing Countries’ Vaccine Regulators 
Network (“DCVRN”) in 2004, under WHO auspices.101  The goal of 
DCVRN is to strengthen regulatory capacity by facilitating discussion and 
increasing exposure to procedures and policies for the evaluation of clinical 
trial proposals and data through the exchange of information and expertise, 
with the aim of generating guidelines and recommendations.102  The 
founding members are Brazil, China, Cuba, India, Indonesia, South Korea, 
Russia, South Africa, and Thailand, but DCVRN activities are to take into 
account the needs of other developing countries that may request help from 
the network.103 
F. Sharing Lessons Learned 
In the broader context of health system policy, emerging countries’ 
public health and health care systems offer both positive and negative 
lessons about health development.  Such lessons can stand as role models 
or warnings for health policy-making in the developing world.  The positive 
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role models underline the importance of an egalitarian ethos and 
government attention to health and social spending.  Brazil, for example, 
has achieved successes in both its public health programs and health system 
development.  At a foundational level, a strong and clear commitment to 
universality and equality motivates Brazil’s health system.  This commitment 
is visible in numerous system components. In its 1988 National Constitution, 
for instance, Brazil established health care as a “right of all and the duty of 
the state.”104  The Unified Health System was created, under which 
government health priorities, planning programs, and resource allocation 
are decided with the participation of state and local health councils and 
consumer representation.105  Civil society health advocacy groups, including 
those working with sex workers and intravenous drug users, receive 
government funding.106  In the early 1990s, as part of a set of health policy 
reforms, the Brazilian government developed the Family Health Program 
(“FHP”), designed to reach out and serve poor families in rural areas; by 
2009, the program has expanded to reach nearly fifty percent of the 
population.107  As early as the 1940s, the Brazilian government, with United 
States assistance, had set up another outreach program targeting the 
populations of the Amazon.108  This program, eventually absorbed into the 
Brazilian Ministry of Health, sought to address a wide range of health issues, 
from water and sanitation systems to the control of infectious diseases like 
malaria and Chagas.109  A recent discussion of this program suggests it has 
“many lessons for the planners of health and disease control projects in 
tropical, low-income countries.”110  Brazil’s powerful egalitarian ethos has 
shaped these initiatives. 
The Indian state of Kerala has long been viewed as not only exemplary, 
but a model for “the rest of India and third world countries in providing 
primary health care.”111  Even though Kerala is quite poor economically, 
with a per capita income of one percent of the highest-income countries, 
Kerala has achieved low infant mortality rates and high life expectancy with 
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very modest investments in health care.112  As in Brazil, an egalitarian ethos 
permeates the system in Kerala, which boasts a “relatively fair distribution of 
wealth and resources across nearly the entire population of the state,”113 as 
well as high female literacy and a strong political commitment to social 
spending.114  Kerala also has a potpourri of other social investments, 
including, for example, a public distribution system for subsidized essential 
foods, land reforms that benefit the poor and landless, and a strong 
transportation and communication infrastructure.115  These, too, are 
programs to emulate. 
Other currently and formerly emerging countries provide models and 
pointers for health policy reforms.  Morocco, Mexico, and South Korea are 
examples of countries undertaking the expansion of health insurance 
coverage, or, in the case of South Korea, actually attaining universal 
insurance.  In 2005, Morocco approved two reforms, one to expand 
coverage of the payroll-based mandatory insurance for public and formal 
private-sector employees, and the other to cover services for the poor 
through a public fund.116  Despite the competing concerns of various 
stakeholders (e.g., medical professionals worried about compensation and 
insurers uncertain about the effects of reform), in Morocco they have 
reached “substantial agreement around the need for greater solidarity and 
equity in access” to quality care, and also for more resources and 
government oversight.117  This was achieved over a fifteen-year debate 
involving politicians, health care providers, employers, trade unions, 
insurers, national social security funds, international organizations and 
donors, NGOs, and the public, showing the importance of broad 
consultation with and participation by affected parties.118 
The Mexican reform launched in 2003 aims to redress the segmentation 
of its health system.  The new Popular Health Insurance scheme (“PHI”) 
supplements the two older insurance schemes that cover private-sector 
workers, government workers, and their families; it offers subsidized, publicly 
 
 112. K.R. Thankappan, Some Health Implications of Globalization in Kerala, India, 79 
BULL. WORLD HEALTH ORG. 892, 892 (2001). 
 113. Id. 
 114. Id. (accounting for about forty percent of the total expenditure).  See also 
InfoChangeIndia.org, State Wise Social Sector Spending as Percentage of Total Expenditure, 
http://infochangeindia.org/200210025816/Governance/Statistics/State-wise-social-sector-
spending-as-percentage-of-total-expenditure.html (last visited Sep. 3, 2010) (describing the 
growing percentage of social sector spending between 2001 and 2004). 
 115. Thankappan, supra note 112, at 892. 
 116. Jennifer Prah Ruger & Daniel Kress, Health Financing and Insurance Reform in 
Morocco, 26 HEALTH AFF. 1009, 1009 (2007). 
 117. Id. at 1011. 
 118. Id. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2010] EMERGING AND TRANSITIONING COUNTRIES’ ROLE IN GLOBAL HEALTH 269 
provided health insurance to the fifty million who were left behind by those 
programs.119  Attainment of universal coverage is projected for 2011.120  
One emphasis of this reform is solidarity.  The federal government’s fixed 
contribution for each family is equal across all three insurance schemes, 
which promotes solidarity among the population, regardless of work 
status.121  Another funding component involves the federal government and 
“co-responsible contributor[s],” which are state governments for PHI.122  
Here, federal contribution is not fixed, but is “increased for poorer states at 
the expense of those that are wealthier.”123  This promotion of universal 
protection and fair financing echoes the egalitarianism underlying the public 
health successes of Brazil and Kerala. 
South Korea, now a fully developed country, exemplifies one route to 
universal national health insurance.  Like China, South Korea developed 
quite rapidly.  In the span of twelve years, 1977-1989, it achieved universal 
health insurance through government-mandated coverage expansions that 
first targeted large firms with more than 500 employees, then the public 
sectors and smaller firms, and finally, remaining rural and urban 
residents.124  Up until 1996, South Korea had been able to fund its national 
health insurance without deficits.125  The 1997 Asian financial crisis 
contributed to funding problems, but the main causes have been traced to 
the government’s shortcomings in regulating the supply of costlier medical 
specialists relative to the supply of generalists, controlling excessive use of 
expensive technologies by private hospitals and facilities, limiting out-of-
pocket expenditures, reforming its pharmaceutical industry and regulatory 
framework, and countering the multinational pharmaceutical companies’ 
promotional campaigns for expensive drugs.126  But despite these difficulties 
in supply-side market regulation, South Korea demonstrates that universal 
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health coverage can be achieved alongside economic development, and 
within a relatively brief time. 
In contrast to these role models, the experiences of China, Russia, and 
India (beyond Kerala) are object lessons that admonish against insufficiently 
regulated and excessive privatization and decentralization, and reveal the 
continuing importance of state stewardship of national health systems. 
India’s public health system “stagnated even as incomes have 
grown.”127  Decline in government spending and limited health insurance 
coverage are major contributors to poor performance.128  The pressure to 
increase economic growth and India’s IMF-mandated structural adjustment 
in the 1990s led to regressive policies such as the reduction of resources for 
health and social sectors.129  User fees were imposed for public health 
facilities.130  Only about fifteen percent of the Indian population has health 
insurance of any kind.131  Out-of-pocket (“OOP”) payments as a 
percentage of income in India exceeded ten percent for all residents except 
the richest urban quintile in 2004, and less well-off households risk sinking 
below the poverty line because of OOP payments.132  Health spending as a 
percentage of gross domestic product (“GDP”) increased from three and a 
half to five percent between 1988 and 2000, but this increase partly reflects 
“waste and inefficiency.”133  Inadequately regulated privatization has 
spurred overprescription of drugs and tests and unnecessary use of 
technology in richer locales, while public budget cuts have contributed to 
drug shortage and worker absenteeism in less prosperous areas.134  Even 
Kerala, India’s success story, is not immune.  Household health expenditures 
in Kerala went up about 517% between 1987 and 1996, driven by 
increasing privatization and rising drug prices.135  Additionally, many 
Keralite health professionals leave the public sector, especially in rural 
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primary care clinics, because they are drawn to more lucrative private sector 
work,136 thus further eroding the strength of Kerala’s public health system. 
In China, economic reforms since 1978 “destroy[ed] the nation’s public 
health system,” leaving “much of the population” uninsured and 
unprotected from health-related financial risks.137  Before 1979, China 
provided “near-universal” coverage through the Cooperative Medical 
Scheme (“CMS”) in rural areas, and the Government Insurance Scheme 
(“GIS”) and Labor Insurance Scheme (“LIS”) in urban areas.138  Reform of 
the rural economy in 1979 established the Household Responsibility System, 
which replaced the communes that financed CMS.139  Ninety percent of 
peasants were left uninsured by the disintegration of that insurance 
scheme.140  GIS and LIS were replaced by a city-based social health 
insurance scheme that only covered formal-sector workers and excluded 
their dependents, migrants, and informal-sector workers.141  Changing from 
a centrally planned economy to one based on market competition shrank 
the Chinese state sector and lowered government revenue.142  Health 
spending came to be seen as a low-priority budget item, and government 
spending as a proportion of health spending decreased from approximately 
thirty percent to around fifteen percent.143  By the early 1990s, government 
subsidies as a portion of public health facilities revenue fell to just ten 
percent.144  In a bid to keep services affordable, the government set below-
cost prices for basic health care, but it set high prices for drugs and high-
tech diagnostic services to keep facilities solvent.145  These moves created 
problematic incentives; when public health facilities had to realize ninety 
percent of their revenues from moneymaking activities, they became profit 
seekers.146  Service provision is down, and costs are up.  In rural areas, the 
lowest income quintile spends about twenty-seven percent of its income on 
OOP payments; in 2003, almost fifty percent of those reporting illness had 
forgone outpatient care, and almost forty percent of that group cited 
finances as the reason.147  In response to these access problems, China in 
2009 launched a health initiative to achieve insurance coverage of essential 
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health services for ninety percent of the population by the end of 2010, with 
the goal of universal coverage by 2020.148  To this end, the government has 
so far committed $125 billion over three years.149 
Russia is probably the most vivid example of a wholesale public health 
system collapse.  Since the demise of the Soviet Union, Russia has taken 
what some call the “Great Leap Downward,”150 whereby reversals in health 
achievements have been the norm rather than the exception, especially with 
regard to cardiovascular diseases and drug- and alcohol-related injuries 
and poisoning.151  Moreover, between 1990 and 1994, there was a fifty-
fold increase in diphtheria, and a doubling in TB prevalence between 1991 
and 1998.152  Russia’s government spending on the health care system has 
severely contracted—in a mere three years, it dropped from 6.2% of GDP in 
2002 to three percent just prior to 2006.153  Goods and services have been 
decentralized, leading to reduced access and quality, higher costs, and a 
weakening of the overall infrastructure.154  The system falls short of meeting 
the health needs of people living with HIV and AIDS.  Russia has around 
seventy percent of all HIV cases in Eastern Europe and Central Asia, with 
one of the world’s fastest growing HIV epidemics, yet only six to fifteen 
percent of those in need have access to antiretroviral treatment (“ART”).155  
In a lesson of what to avoid in health systems management, the Soviet 
Ministry of Health built a “separate centralized network of AIDS centers,” not 
integrated into the broader health care system.156  Observers in 2006 
remarked that, “to this day,” providers in the AIDS centers “generally 
remained poorly trained and informed about the disease.”157  Abstinence-
based programs and deficits in addressing transmission among intravenous 
drug users have also contributed to failures in HIV/AIDS care, as in other 
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parts of the world.158  One bright spot in Russia’s AIDS picture, with positive 
lessons for other countries, is its exemplary program to prevent mother-to-
child transmission.159 
Incentives are important for the design and performance of health 
programs, and inadequate consideration for economic realities can 
generate perverse incentives and outcomes.  South Africa’s Disability Grant 
is a case in point.160  This grant is meant to ensure that HIV/AIDS patients 
can afford adequate nutrition and transportation to clinics.161  Eligibility is 
“temporary and contingent” on the recipient’s CD4 count.162  The Disability 
Grant is the “only form of social security available to working-age adults in 
South Africa.”163  This proves unfortunate in a country with an 
unemployment rate that hovers around forty percent; since jobs are so 
scarce, the Disability Grant is frequently used to support whole families, 
rather than merely to supplement HIV/AIDS treatment.164  Patients are 
believed to default on treatment in order to keep the grant, although more 
recent empirical research has called this into question.165  Fearing fraud, the 
South African government has strengthened enforcement during the annual 
grant review, causing many patients to lose the grant after commencing 
ART.166  Chinese pricing of health services, as described earlier, also creates 
counterproductive incentives that undermine medical professional ethics and 
norms.167  Seeing the need for incentive reform, the Chinese government 
has encouraged cities and localities to experiment with various schemes, 
many of which involve switching from retrospective fee-for-service payment 
to aggregated and prospective payment methods with performance-linked 
incentives.168 
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The cautionary examples of India, China, Russia, and South Africa show 
that health systems cannot be developed or maintained in isolation from 
other social and economic challenges and government policies.  They are 
arguments for a comprehensive, multi-sector approach to health system 
development and health policy-making. 
G. Expanding Economies and Reducing Poverty 
As discussed above, emerging countries like BRIC are in position to 
provide other developing countries with financial, material, and technical 
assistance, and to model both positive and negative lessons in public health 
and health care development.  With their burgeoning economies and rising 
regional and international clout, BRIC also have the ability to help 
developing countries address the economic determinants of health, by 
assisting with the expansion of their economies and the reduction of poverty, 
which is associated with poor health.  A growing economy provides the 
necessary resources for health system development, both initial investments 
and recurring expenditures. 
Regional trade agreements (“RTA”) are one way to open markets to 
developing countries.  These preferential trade agreements reduce tariffs 
and restrictions on trade among members; some may also apply a common 
external tariff toward non-members, or perhaps engage in even deeper 
economic integration, such as common currencies.169  The BRIC countries 
are involved in a number of RTAs.  Brazil is part of Mercosur, the full and 
associate members of which include Argentina, Paraguay, Uruguay, 
Venezuela, Bolivia, Chile, Colombia, Ecuador, and Peru.170  Mercosur is a 
free trade zone and a customs union, with aims toward a common 
currency.171  Russia has been a member of the Eurasian Economic 
Community (“EAEC”) since 2000, along with Belarus, Kazakhstan, 
Kyrgyzstan and Tajikistan; Armenia, Moldova, and the Ukraine are 
observers.172  The goals of EAEC include the free trade of goods, 
encouragement of investments, a common market for energy, and a 
common system for customs regulation.173  To deepen the EAEC economic 
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integration process, Russia announced plans to establish a Common 
Economic Space with Belarus and Kazakhstan, which entails a customs 
union effective this year.174  China and India both have free trade 
agreements with the Association of Southeast Asian Nations (“ASEAN”) 
starting this year, opening up their markets to the Southeast Asian countries 
of Brunei, Myanmar, Cambodia, Indonesia, Laos, Malaysia, Philippines, 
Singapore, Thailand, and Vietnam.175  India also has a preferential trade 
agreement with Mercosur.176  These are prominent examples of RTAs. 
Because of lower tariffs, regional trade partners benefit from cheaper 
goods for consumers.  For instance, average tariff rates on both Chinese 
goods sold in ASEAN countries and ASEAN goods sold in China has 
decreased to near zero.177  Trading partners additionally gain access to new 
markets for export, which profits domestic businesses.  However, RTAs are 
not simple instruments; though they liberalize trade among member states, 
RTAs may have negative consequences such as encouraging costlier imports 
from member countries at the expense of less expensive goods from non-
members, which could potentially harm consumers in these developing 
countries.178  There are also concerns that industries and sectors in the 
smaller trading partners’ economies may not be able to withstand 
competition from the BRIC economies, especially China.179 
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Yet RTAs can also be designed to ensure aid to development.  South 
Africa anchors a free trade arrangement that has an explicit development 
component, the Southern African Customs Union (“SACU”).180  This customs 
union provides for free trade among South Africa, Botswana, Lesotho, 
Namibia, and Swaziland, and erects a common external tariff and a 
common excise tariff for the group.181  South Africa acts as the custodian of 
the Revenue Fund, into which all common customs revenue is paid.182  
Revenue is distributed to Botswana, Lesotho, Namibia, and Swaziland in 
accordance with a revenue-sharing formula, with South Africa retaining the 
residuals.183  A portion of SACU revenue derived from the excise tariff is 
earmarked for development.184  This portion is calculated for member 
countries based on the inverse of each country’s per capita GDP,185 thus 
serving a redistributive function. 
Economic assistance comes in other forms as well.  China, for example, 
announced an aid package for ASEAN worth billions of dollars to further 
China-ASEAN cooperation.186  The aid includes investments in infrastructure 
construction, energy, information, and communications; preferential loans; 
scholarships; and rice for the emergency East Asia rice reserve.187  In 2007, 
China set aside for Africa about five billion dollars in investments and 
another five billion dollars in loans and credits, with no political strings 
attached.188  In 2005, Russia, as a member of the G8, participated in 
forgiving at least forty billion dollars in debt for eighteen of the world’s 
poorest countries.189  Debt relief and development assistance can redirect 
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national spending away from debt service and toward health and social 
spending.  As such, they can be a “vital element” in meeting the Millennium 
Development Goals for health.190 
Economic assistance does not have to be monetary.  Brazil, for instance, 
strengthened the ability of developing countries to participate effectively in 
WTO agricultural negotiations by leading the organization and coordination 
of G20.191  G20 members have disparate, even conflicting positions in 
agricultural negotiations, but Brazil’s technical experts from government and 
the private sector played a large part in generating technically consistent 
proposals that brought G20 recognition as a major new actor in agricultural 
negotiations.192  To the extent that such efforts improve the trading positions 
of developing countries, they confer economic advantages. 
H. Taking a Role in Global Health Governance 
Emerging countries have a role in global health governance.  A 
multiplicity of actors and agendas characterizes the current global health 
architecture.  The actors include (but are not limited to) the World Bank, 
WHO, UNAIDS, UNICEF, NGOs, think tanks, The Global Fund, entities 
such as the Gates, Ford and Rockefeller foundations, the EU, the USA, other 
developed countries, and now emerging countries.193  The growth of 
emerging countries as major new international players with political and 
financial clout to influence global and domestic health agendas adds to the 
global health architecture’s pluralism and fragmentation, possibly 
exacerbating the lack of coordination and the often ad hoc nature of the 
global health agenda.194  Emerging countries’ activities would have greater 
chances of success if players took effective steps to avoid duplication and 
inadvertent conflict with the efforts of other global health actors and 
funders.195  This need creates an even more compelling rationale for an 
overarching institution to set the global agenda and coordinate policy.196  
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The WHO is one possibility in this regard.197  The general wish of the global 
health community for more coordination might be seen in the election of 
Margaret Chan as WHO Director-General in 2006, which was described by 
some as reflective of “[i]nternational desire for more cooperation from 
China.”198 
There is another story to be told about emerging countries’ role, 
however—about their potential as counterbalance or counterforce to more 
“powerful” countries.  Brazil, Russia, India, and China publicly declared 
themselves a cooperative group with the first BRIC summit.199  There, BRIC 
issued joint statements that, among other things, called for greater 
representation of emerging and developing economies in international 
financial institutions, and comprehensive reform of the United Nations to 
include greater status for India and Brazil.200  This BRIC summit followed 
directly on the heels of a meeting of the Shanghai Cooperation 
Organization (“SCO”), a regional forum for security and economic 
cooperation of Central Asian states, led by Russia and China.201  The desire 
to counterbalance the established powers is clear in “a common thread” at 
the SCO and BRIC summits, the “discussion of a new world order less 
dependent on the United States.”202 
The BRIC countries act in other combinations as well.  Brazil, India, and 
South Africa, for example, formed a “trilateral alliance” in 2003 called the 
India, Brazil, and South Africa Dialogue Forum (“IBSA”) to coordinate and 
“maximize joint actions” in pursuit of mutual interests within international 
organizations like the WTO.203  The intent was to “hold regular political 
consultations”, share information, and coordinate positions.204  Some of the 
issues addressed by IBSA include pharmaceutical patents, public health, and 
government subsidies.205  IBSA as a bloc has also sought alliances with 
other countries such as China and Argentina around specific global issues 
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like agricultural policy and subsidies.206  Thus, IBSA, and those with which it 
coordinates, aim to use their collective clout to win concessions on issues of 
special relevance.207  This “soft balancing” technique combines economic, 
diplomatic, and institutional tools to challenge the position of major 
powers.208  It may be a harbinger of negotiations to come as emerging 
countries both develop and cooperate more effectively. 
Some BRIC countries have transitioned to more “elite” status in global 
governance and thus assume greater political weight.  Russia, for example, 
is a member of G8,209 and even though the G8 is more of a supplemental 
global health governance model with a decidedly top-down aspect, it is 
nonetheless influential.  As G8 president in 2006, Russia committed to 
increasing the importance and visibility of HIV/AIDS as a central theme of 
G8 action, despite its own HIV/AIDS failures, and emphasized the need to 
meet existing pledges and commitments as opposed to starting completely 
new endeavors.210  Russia also reached out to the other BRIC countries, 
South Africa, and Mexico to participate in an April 2006 health ministerial 
session in Moscow.211  Regionally, Russia was active in coordinating a 
Commonwealth of Independent States (“CIS”) Inter-Parliamentary Assembly 
working group in 2002 that drafted a model law, “On Prevention of 
Spreading of HIV/AIDS in CIS Countries,” and hosted a 2005 ministerial 
meeting, “Urgent Response to HIV/AIDS Epidemics in the Commonwealth of 
Independent States,” in Moscow.”212  From that meeting came the Moscow 
Declaration emphasizing the need to scale up HIV responses in CIS.213  
Moscow then hosted, in 2006, the first regional Eastern European and 
Central Asia AIDS conference.214 
I. Linking Health and Foreign Policy 
Health issues are becoming an important focus in foreign policy.  
Global interdependence with its massive volumes of international trade and 
travel means that health hazards anywhere in the world can potentially 
threaten citizens of every country.  Border-crossing infectious diseases (like 
SARS and influenza) and the specter of bioterrorism place health within the 
national security realm.  HIV/AIDS poses serious risks to international and 
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regional stability by disrupting the demographic, social, economic, and 
political structures of states.  Economic interests are at issue, too, since 
healthy populations—which are more productive and likely to have more 
disposable income—are better workers and consumers who contribute more 
to economic growth.215  For countries confronting overwhelming health 
challenges, such as those in sub-Saharan Africa, foreign policies concerning 
access to drugs and resources for health programs may be, without much 
exaggeration, a matter of national survival.  The signs of health’s 
ascendance in foreign policy are clear.  The United Nations Security Council 
debated HIV/AIDS for the first time in 2000, the same year the leading 
world economies comprising the G8 committed to the establishment of the 
Global Fund.216 
The treatment of health as a national economic and security interest 
elevates health’s status in international relations, and along with that come 
more attention and resources.  Health becomes an investment in economic 
productivity, harm prevention, and future cost savings.217  This “investment-
based global-health debate” basically makes the argument of “increased 
interdependence, threat to the rich countries if they do not act, and great 
economic benefits for all if they do.”218  It is a simple, compelling appeal to 
enlightened self-interest.  This argument has important policy implications, 
specifically that “the global disease burden must be explained by a lack of 
good governance, of money, and of efficiency in implementation,” and not 
by “inherently political decisions and the distribution of power.”219  This 
obscures the real effects of the fundamental international disparity in 
economic and political power.  For example, developing countries’ tropical 
diseases are ignored in pharmaceutical research and development—which 
takes place largely in advanced industrialized countries—because poor 
countries do not have the economic power to render such ventures 
profitable.220  Out of the 1,223 new chemical entities brought to market 
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between 1975 and 1997, only one percent are for tropical diseases, and 
only 0.3% were direct products of pharmaceutical—as opposed to military 
or veterinary—research and development.221  A low-income country with 
good governance and efficient policy implementation would still have 
trouble with disease burdens if the necessary drugs do not exist. 
The national interest approach to health exists in tension with an 
approach that calls for a global and provincial consensus on the morality of 
health.222  National interest does not necessarily value health for its own 
sake.  It does not take the view that health is a special social good, which 
every country has a responsibility to promote, particularly among its own 
citizens but also among citizens of the world.  Rather, health as a national 
interest is handled politically, not medically, nor always in an evidence-
based manner.  G8 countries, which established the Global Fund for AIDS, 
Malaria, and Tuberculosis, take little action on tobacco, a major cause of 
chronic illness and a public health threat.223  Health got onto the foreign 
policy agenda, but it is still a relatively low priority.224  When health comes 
into conflict with powerful economic interests—such as the pharmaceutical 
industry—it is likely to end up on the losing side. 
Why is a discussion of health and foreign policy important for BRIC?  To 
a global health approach that privileges health as a special social good, 
distinct and separate from other social goods like economic growth and 
trade, BRIC can contribute many useful lessons.  Their experiences and 
ongoing challenges show that health does not need to be—and should not 
be—sacrificed or traded off in the pursuit of economic growth.  An inclusive 
approach that sets priorities and allocates resources in consultation with 
affected parties and which gives extra help to the most disadvantaged 
should be taken.225  Some of the emerging countries already practice this 
type of health governance at the national or local level.  The egalitarianism 
of the Brazilian, Keralan, and Mexican public health systems, the strong civic 
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engagement of the highly lauded Brazilian HIV/AIDS program, and the 
deliberative process and consensus achieved in Moroccan health reform are 
a few examples of this type of health governance at work.226 
As emerging countries gain a more powerful voice in international 
affairs, they can draw attention to their successes and help take “shared 
health governance” to the global level through leading by example.  With 
growing economic and political strength, these countries can make more 
forceful demands for the collective agency of the developing world, so that 
the needs and interests of recipient states can be properly considered and 
accounted for in global and international health action.  And these countries 
can increase their individual and collective clout in international 
organizations and advocate for the need to coordinate policies across 
sectors—such as trade and health—to improve health outcomes. 
As we have seen, BRIC are now featured prominently in political 
relationships at the regional and global level and in international diplomatic 
relations.  Emerging countries like the BRIC nations are becoming economic 
and political forces to be reckoned with, but they also bring the concerns 
and claims of the developing world to the foreign policy table.  In the arena 
of essential drugs, for instance, they have already made notable progress in 
shifting norms toward a duty to access. 
To promote the integration of health issues in foreign policy, several 
emerging countries have participated in the launch of the Foreign Policy and 
Global Health Initiative (“FPGH”).227  Participants are Brazil, France, 
Indonesia, Norway, Senegal, South Africa, and Thailand.228  This is a step 
toward “a more sustainable relationship between foreign policy and 
health.”229 
III.  SOME NECESSARY CAVEATS 
A. Emerging and Transitioning 
Emerging and transitioning countries—especially BRIC—have great 
potential to help shape global health.  Still, while these countries may be 
emerging economically, their public health and health care systems do not 
necessarily match their economic advancements.  Many aspects of these 
systems still need development, and emerging countries will require 
assistance and support from the industrialized world. 
 
 226. See supra section II, sub-section F. 
 227. Margaret Chan et al., Foreign Policy and Global Public Health: Working Together 
Towards Common Goals, 86 BULL. WORLD HEALTH ORG. 498, 498 (2008). 
 228. Id. 
 229. Id. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2010] EMERGING AND TRANSITIONING COUNTRIES’ ROLE IN GLOBAL HEALTH 283 
Numerous health challenges confront these countries.  For example, 
Brazil’s HIV/AIDS response is a salient public health success, but gaps exist 
even there due to insufficient resources.230  It is “not uncommon” to find 
untreated HIV patients in Rio emergency rooms,231 and drugs are not always 
available in Brazilian pharmacies, leading citizens to sue the government for 
drug access.232  Brazil’s tuberculosis control program is also much less 
successful than its HIV/AIDS effort.233 
Russia’s health outcomes have been suffering under the post-Soviet 
decentralization of the public health system, but, in addition, it is 
experiencing a rapid and significant increase in alcohol and substance 
abuse.  Per capita alcohol consumption in Russia more than doubled 
between 1987 and 2001, from about five liters a person to more than 
ten.234  In 2006, Russia had over 300,000 registered drug dependents, and 
experienced more than 240,000 drug-related crimes, up twenty-three 
percent from 2005.235  Both alcohol and substance abuse put individuals at 
risk for physical health problems such as tuberculosis, hepatitis, HIV/AIDS, 
and other sexually transmitted diseases,236 and more generally, mental 
health disorders237 and injuries from auto accidents.238  Russia has one of 
the world’s fastest growing HIV epidemics and accounts for the bulk of HIV 
cases in Eastern Europe and Central Asia.239 
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India has a relatively low national HIV/AIDS prevalence rate—about 
0.3% in 2008240—but the sheer size of its population means that even at 
this rate, India has the world’s third largest number of people living with 
HIV/AIDS.241  Even small upward movements in the prevalence rate would 
mean big increases in the number of patients and in the demand on India’s 
health system.242  More revealing of India’s health system weaknesses is its 
high maternal mortality rate, estimated by UNICEF at around 450 per 
100,000 live births,243 compared to China’s rate of about fifty per 100,000 
live births.244  Major causes for such a high rate include the lack of primary 
healthcare facilities, the dearth of skilled birth attendants, corrupt health 
workers who extort women for money or withhold care, and the prevalence 
of anemia among women due to poor nutrition.245 
Inadequate human and physical resources hamper China’s HIV/AIDS 
response.  Local governments are responsible for implementing and funding 
patient treatment, but resources are limited and local officials may have 
incentive to downplay the HIV issue for fear of deterring investments.246  A 
lack of qualified teachers and education materials likewise undermines HIV 
education efforts.247  As the largest producer and consumer of tobacco in 
the world, China has over 320 million smokers, or about a third of all 
smokers worldwide.248  Between 1980 and 1990, tobacco consumption 
increased by 7.2% per year, mainly from new teenage smokers.249  This 
poses significant health problems: predicted deaths attributed to smoking 
are expected to reach three million in 2050; over two-thirds of smoking-
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related deaths are due to respiratory conditions such as chronic obstructive 
pulmonary disease, lung cancer, and tuberculosis.250 
South Africa continues its struggle with HIV/AIDS.  It has “the largest 
[ART] program in the world,” but also “the world’s largest epidemic.”251  
Less than a third of the infected population received treatment in 2007.252  
Efforts to prevent mother-to-child transmission are unsatisfactory, with South 
Africa’s 2008 guidelines criticized as being below WHO standards.253  
Education campaigns are failing due to lack of teachers and the lack of 
incentive for teachers to train, with the result of widespread ignorance of 
preventive methods.254  Less than half of the South African population, 
across all age groups and sexes, were aware of the preventive effects of 
condom use and fewer sex partners.255 
B. Still Needed: Assistance from the Global Community 
The alarming health problems facing BRIC and their still-developing 
health systems make clear their need for continuing assistance from the 
global health community.  Attention should focus especially on public health 
surveillance and control of infectious agents, and on health system 
development.   
The case of SARS exposed significant gaps in the Chinese public health 
surveillance system, specifically its design and vulnerability to political 
considerations.  The inefficient reporting process resulted in disease 
information passing sequentially through local, provincial, and central levels 
of authority before reaching officials who had the power to act.256  “Top 
secret” designation for such information precluded interprovincial 
information sharing until the Ministry of Health gave permission.257  Personal 
and political incentives further limited information flow as various officials 
suppressed news of the SARS outbreak to protect trade and investments, to 
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shield the image of the Chinese Communist Party, and to maintain social 
stability.258  Chinese delays in reporting the disease were such that WHO 
publicly criticized China as uncooperative in April 2003.259 
The SARS episode shows that emerging countries still need assistance 
from global health institutions for the necessary resources and technical 
oversight in disease surveillance, reporting, and monitoring.  International 
normative pressure may also help increase media access and spur a more 
open and transparent outbreak response.  Indeed, in the international 
fallout from its SARS response, China—and any other country that was 
paying attention—could see that inadequate outbreak response could cause 
more economic and reputational damage than the outbreak itself.  Its 
response to H1N1 was accordingly much more public and aggressive.260  
The global health community, especially international organizations such as 
WHO, has a convincing rationale for working with emerging and 
developing countries to ensure the best possible outcomes from infectious 
disease outbreaks. 
Health system development also calls for continuing international 
assistance.  As discussed in the previous section, all the BRIC nations have 
health systems suffering at least from insufficient resources and at worst from 
near collapse, in the case of Russia.  Help is critical to repair and develop 
these systems, all of which face daunting challenges including HIV/AIDS, a 
focal issue in global health.  Screening and treatment programs need to 
improve and expand.  For example, about a quarter of Chinese respondents 
in a 2008 survey did not know where they could get tested for HIV/AIDS.261  
Access to antiretroviral treatment was available to only six to fifteen percent 
of Russian AIDS sufferers in 2006,262 and to about nineteen percent of 
Chinese AIDS patients in 2007.263  Stigma and discrimination against AIDS 
sufferers and sometimes even official intolerance of high-risk groups—
especially intravenous drug users—must be reduced to enable better 
outreach and treatment.  BRIC already receive funds from global donors 
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such as the World Bank, the Global Fund, and the Gates Foundation for 
their HIV/AIDS programs; the need endures. 
HIV/AIDS touches on other aspects of health systems too.  Blood 
collection and blood supply must become safe and secure, in light of mass 
infections of Chinese blood and plasma donors and recipients through 
unsafe practices.264  Quality control for drug and health products must 
improve.  Almost 44 percent of Chinese condoms tested failed key 
requirements, according to a 2001 government survey,265 and the quality of 
active drug ingredients manufactured by Indian and Chinese companies are 
not always reliable.266  Financial and technical assistance from the global 
health community would benefit efforts to address these issues.  
International norms and pressure may also help ensure that HIV/AIDS 
programs are consistent with human rights.  There are concerns, for 
instance, about the involuntary nature of HIV testing conducted in Chinese 
and Indian hospitals, and about the repression of NGO advocacy in 
China.267  It is not clear, however, how effective human rights efforts would 
be in China, given its unwillingness to engage these issues. 
Non-communicable diseases affect developing countries as they 
increasingly experience the health threats typical of more developed 
societies.  Almost sixty percent of global deaths and close to half of the 
global disease burden are due to non-communicable, diet- and inactivity-
related conditions like heart disease, cancer, diabetes, and obesity268; sixty-
six percent of those deaths occur in developing countries.269  Control efforts 
must address globalized food trade, agricultural policy, and regulations on 
marketing, labeling, and ingredients.  The WHO developed a 2004 Global 
Strategy for Diet, Health, and Physical Activity to help prevent and control 
non-communicable diseases,270 but the global community must take further 
steps, which may include working with WTO and other relevant entities to 
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coordinate a coherent response to this emerging but neglected global 
health threat. 
Aside from disease surveillance and health system development, the 
global health community must work with emerging countries to help address 
the bioterrorism threat.  Preventing, detecting, and countering bioterrorism is 
“extremely difficult,” as biological weapons can be cheaply made from 
Internet recipes by those with basic biology and engineering training.271  But 
steps can be taken to limit the risks arising from poor monitoring and 
control of deadly pathogens.  Of prominent concern are repositories like 
Vector, which used to be Russia’s major bioweapons facility.272  Up until the 
early 1990s, this previously well-guarded, well-equipped compound housed 
the only other stock of smallpox virus outside the United States Centers for 
Disease Control and Prevention in Atlanta; it also housed hemorrhagic fever 
viruses like Ebola and Crimean-Congo.273  Less than a decade after the fall 
of the Soviet Union, Vector was “half-empty” and patrolled by “a handful of 
guards who had not been paid for months.”274  Russia—and other countries 
with stocks of dangerous pathogens—must tighten protection and 
monitoring, and the global community should assist financially and 
technically, as well as organize a more coordinated global strategy to deal 
with bioterrorism. 
IV.  CONCLUSION 
This article describes the roles that emerging countries play in global 
health, as the givers and recipients of aid.  It outlines the types of assistance 
emerging countries can render to less developed states, as well as the sort 
of help emerging countries still need from the global health community.  We 
also contemplate the effect of their participation in global health 
governance and their influence on health and foreign policy.  Emerging 
countries—especially the incipient world powers Brazil, Russia, India, and 
China—are in an interesting position.  Their still-transforming economies 
and health systems connect them directly to the concerns of the developing 
world, while their growing economic and political clout give them a place at 
the table with industrialized countries and a more powerful voice in global 
affairs.  The emergence of the BRIC countries as global health actors may 
direct greater attention to the needs and perspectives of developing 
countries.  With appropriate accommodation and effective coordination, 
 
 271. D.A. Henderson, Bioterrorism as a Public Health Threat, 4 EMERGING INFECTIOUS 
DISEASES 488, 489 (1998), available at http://ftp.cdc.gov/pub/EID/vol4no3/adobe/hender 
son.pdf. 
 272. Id. at 488. 
 273. Id. 
 274. Id. 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2010] EMERGING AND TRANSITIONING COUNTRIES’ ROLE IN GLOBAL HEALTH 289 
their expanding role on the world stage should be a positive development 
for global public health. 
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